| Financial Year |
March 31 2023 |
| Monetary Funds |
467,528,703.07 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,869,844.66 |
| Accounts Receivable |
273,960,923.44 |
| Advances to Suppliers |
41,889,070.78 |
| Other Receivables |
12,282,067.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
306,438,713.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
362,543,105.11 |
| Total Current Assets |
1,481,945,478.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,606,846.61 |
| Investment Properties |
17,865,212.41 |
| Fixed Assetes |
443,321,494.23 |
| Under-construction Projects |
289,715,814.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
93,923,506.75 |
| R&D expenses |
7,601,029.40 |
| Goodwill |
131,048,717.28 |
| Long-Term Deferred and Prepaid Expenses |
19,272,034.93 |
| Deferred Income Tax Assets |
23,098,060.69 |
| Other Non-Current Assets |
39,840,485.66 |
| Sub-Total of Non-Current Assets |
1,103,224,127.37 |
| Total Assets |
2,585,169,605.44 |
| Short-Term Loans |
209,996,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
36,562,266.39 |
| Accounts Payable |
193,660,845.54 |
| Accounts Received In Advance |
156,880.74 |
| Employee Compensation Payable |
20,329,166.19 |
| Taxes Payable |
7,485,544.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
116,558,497.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,448,553.05 |
| Other Current Liabilities |
5,835,433.05 |
| Sub-Total of Current Liabilities |
673,808,834.57 |
| Long-term Loans |
107,520,000.00 |
| Bonds Payable |
187,726,388.45 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,744,362.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
375,265,520.44 |
| Total Liabilities |
1,049,074,355.01 |
| Paid-In Capital(Or Share Stock) |
175,789,211.00 |
| Capital Surplus |
505,550,059.21 |
| Surplus Reserve |
77,212,938.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
634,965,327.28 |
| Minority Stockholder's Interest |
91,083,862.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,445,011,388.04 |
| Owner's Equity（Stockholder's Equity） |
1,536,095,250.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,585,169,605.44 |
